Expression Therapeutics
John Kolb worked as a Research Assistant at The University of Georgia for the Meile Group from February 2018 to May 2021. John then transitioned to Expression Therapeutics, Inc. as a Senior Scientist in May 2021, where John continues to work on planning and optimizing experiments for the T cell oncology program.